Pieris Pharmaceuticals, Inc.
News
PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders
Business Wire Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and Palvella Therapeutics, Inc. is fair to Pieris shareholders...\n more…
Pieris Pharmaceuticals (NASDAQ:PIRS) Share Price Crosses Above 50 Day Moving Average of $12.14
Ticker Report Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS - Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $12.14 and traded as...\n more…
Pieris Pharmaceuticals (NASDAQ:PIRS) Downgraded to Sell at StockNews.com
Ticker Report StockNews.com downgraded shares of Pieris Pharmaceuticals (NASDAQ:PIRS - Free Report) from a hold rating to a sell rating in a research note published on Friday. Pieris Pharmaceuticals Trading Up 2.2...\n more…
Pieris Pharmaceuticals Second Quarter 2024 Earnings: US$2.76 loss per share (vs US$3.63 profit in 2Q 2023)
Simply Wall St Pieris Pharmaceuticals ( NASDAQ:PIRS ) Second Quarter 2024 Results Key Financial Results Net loss: US$3.59m (down by...\n more…
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. - PIRS
PR Newswire SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. - PIRS SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of...\n more…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of Shareholders
Globe Newswire NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...\n more…